GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GCM1 | hg38_v1_chr6_-_53148822_53148846 | 0.14 | 4.0e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_10164883 Show fit | 32.60 |
ENST00000256458.5
|
interleukin 1 receptor associated kinase 2 |
|
chr22_+_22822658 Show fit | 22.87 |
ENST00000620395.2
|
immunoglobulin lambda variable 2-8 |
|
chr22_+_22758698 Show fit | 21.54 |
ENST00000390312.2
|
immunoglobulin lambda variable 2-14 |
|
chr22_+_22734577 Show fit | 20.27 |
ENST00000390310.3
|
immunoglobulin lambda variable 2-18 |
|
chr2_+_90069662 Show fit | 20.26 |
ENST00000390271.2
|
immunoglobulin kappa variable 6D-41 (non-functional) |
|
chr22_+_22588155 Show fit | 19.79 |
ENST00000390302.3
|
immunoglobulin lambda variable 2-33 (non-functional) |
|
chr2_-_89160329 Show fit | 19.71 |
ENST00000390256.2
|
immunoglobulin kappa variable 6-21 (non-functional) |
|
chr2_+_90021567 Show fit | 19.70 |
ENST00000436451.2
|
immunoglobulin kappa variable 6D-21 (non-functional) |
|
chr2_-_89330429 Show fit | 19.24 |
ENST00000620613.1
|
immunoglobulin kappa variable 2-40 |
|
chr22_+_22697789 Show fit | 17.74 |
ENST00000390306.2
|
immunoglobulin lambda variable 2-23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 148.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.9 | 127.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.4 | 32.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.8 | 24.8 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 18.5 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 14.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
1.3 | 12.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.7 | 12.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 10.6 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 9.9 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 170.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 74.9 | GO:0005886 | plasma membrane(GO:0005886) |
0.1 | 32.5 | GO:0010008 | endosome membrane(GO:0010008) |
1.2 | 24.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 16.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 15.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 12.8 | GO:0005770 | late endosome(GO:0005770) |
3.4 | 10.2 | GO:0008623 | CHRAC(GO:0008623) |
0.0 | 9.3 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 8.7 | GO:0042629 | mast cell granule(GO:0042629) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 216.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 38.5 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
2.3 | 24.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.3 | 12.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 11.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 10.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 9.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 9.6 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 9.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.2 | 8.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 32.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 12.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 8.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 6.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 6.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 4.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 4.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 4.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 3.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 3.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 32.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.1 | 12.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 10.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 8.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 8.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 6.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 6.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 5.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 4.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 4.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |